Literature DB >> 26727652

Non mutagenic and mutagenic DNA damage tolerance.

Sanjay D'Souza1, Kinrin Yamanaka1, Graham C Walker1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26727652      PMCID： PMC4943691          DOI： 10.1080/15384101.2015.1132909

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase.

Authors:  Lauren S Waters; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

2.  Mutants of yeast defective in mutation induced by ultraviolet light.

Authors:  J F Lemontt
Journal:  Genetics       Date:  1971-05       Impact factor: 4.562

Review 3.  Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance.

Authors:  Lauren S Waters; Brenda K Minesinger; Mary Ellen Wiltrout; Sanjay D'Souza; Rachel V Woodruff; Graham C Walker
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

4.  Mutation rates across budding yeast chromosome VI are correlated with replication timing.

Authors:  Gregory I Lang; Andrew W Murray
Journal:  Genome Biol Evol       Date:  2011-06-10       Impact factor: 3.416

5.  Coordination of DNA damage tolerance mechanisms with cell cycle progression in fission yeast.

Authors:  A John Callegari; Thomas J Kelly
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

6.  Rev3, the catalytic subunit of Polζ, is required for maintaining fragile site stability in human cells.

Authors:  Audesh Bhat; Parker L Andersen; Zhoushuai Qin; Wei Xiao
Journal:  Nucleic Acids Res       Date:  2013-01-08       Impact factor: 16.971
  6 in total
  1 in total

1.  Mutational signature distribution varies with DNA replication timing and strand asymmetry.

Authors:  Marketa Tomkova; Jakub Tomek; Skirmantas Kriaucionis; Benjamin Schuster-Böckler
Journal:  Genome Biol       Date:  2018-09-10       Impact factor: 13.583
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.